Thursday 24 June, 13:00-15:00 Central European Time
Prof. Tit Albreht, Senior Health Services and Health Systems Researcher at the National Institute of Public Health of Slovenia
Prof. Albreht is a Senior Health Services and Health Systems Researcher at the National Institute of Public Health of Slovenia. Since 2006, he has been actively involved in the development of cancer policies at the European level, including as a work package leader in the European Partnership for Action Against Cancer (EPAAC), which resulted in the European Guide on National Cancer Control Programmes. Currently, he is the coordinator of the third Joint Action on cancer control, entitled innovative Partnership for Action Against Cancer (iPAAC).
Prof. Mark Lawler, Associate Pro-Vice-Chancellor, Professor of Digital Health, and Chair in Translational Cancer Genomics, Faculty of Medicine, Health and Life Sciences, Queen's University Belfast
Prof. Lawler is a Board Member of the European Cancer Organisation and Co-Chair of its Special Network on the Impact of COVID-19 on Cancer, set-up in order to delineate the challenges that COVID-19 has posed on cancer care and produce recommendations on the most critical and pressing issues.
- How does your organisation engage with your national cancer plan?
- In what areas can the EU Beating Cancer Plan drive progress for cancer control in your country?
Prof. John Kennedy, Consultant Medical Oncologist, St James’s Hospital, Dublin, and Clinical Professor of Oncology, Trinity College Dublin
Prof. Kennedy is a consultant medical oncologist in St James’s Hospital and St Luke’s Hospital, Dublin, specialising in breast cancer. In 2016 he became clinical professor of oncology at Trinity College Dublin. He chaired the Cancer Strategy Steering Group that developed Ireland’s National Cancer Strategy 2017-2026 focusing on the following goals: reducing cancer burden; provision of optimal care; whilst maximising patient involvement with the aim of improving their quality of life.
- Which areas of the cancer system are in need of transformative thinking following the lessons from COVID-19?
- What opportunities for cross-national collaboration are available to make positive progress in those areas?
Held in partnership with the Dutch Cancer Society